Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Will The Endometriosis Market Valuation Change Between Now And 2029?

The market for endometriosis has seen robust growth in the recent past. Anticipated to escalate from a value of $1.4 billion in 2024 to a higher $1.54 billion in 2025, it showcases a compound annual growth rate (CAGR) of 9.8%. Factors contributing to this upward trajectory during the historic period include increased awareness and delayed diagnosis, advancements in laparoscopic surgery, advancements in hormonal treatments, along with the role of patient advocacy and support groups.

It is anticipated that the market size for endometriosis will experience significant expansion in the coming years. It is projected to reach a value of $2.21 billion by 2029, with a compound annual growth rate (CAGR) of 9.4%. The projected surge during this period can be credited to advancements like minimally invasive procedures, pharmaceutical breakthroughs, genetic and epigenetic research, and global broadening of women’s healthcare. Key trends to watch in this forecast period include patient-focused care, precision medicine, virtual care, telemedicine, and the preservation of fertility.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13035&type=smp

What Growth-Enabling Forces Are Impacting The Endometriosis Market?

The escalation in ovarian cancer cases is predicted to fuel the expansion of the endometriosis market in the future. Ovarian cancer originates in the ovaries, the feminine reproductive glands responsible for egg production and for generating hormones such as estrogen and progesterone. High estrogen levels, typical of endometrioid and clear cell cancer subtypes, are associated with endometriosis and can escalate the likelihood of ovarian cancer. For instance, the American Cancer Society, a professional organization based in the US, projected in January 2023 that approximately 19,710 new ovarian cancer diagnoses will occur among US women in 2023. Moreover, according to statistics from the Ovarian Cancer Research Alliance, a non-profit US organization, ovarian cancer was responsible for 12,810 fatalities in 2022 and this figure rose to 13,270 deaths in 2023. Hence, the rising prevalence of ovarian cancer is propelling the endometriosis market’s expansion.

What Are The Main Segment Classifications In The Endometriosis Market?

The endometriosismarket covered in this report is segmented –

1) By Type: Superficial Peritoneal Lesion; Endometrioma; Deeply Infiltrating Endometriosis; Other Types

2) By Treatment Type: Hormonal Therapy; Pain Management

3) By Drug: Oral Contraceptives; Progestins; Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Gonadotropin Releasing Hormone (GnRH) Analogues; Levonorgestrel-Releasing Intrauterine Devices (LNR-IUDs); Other Drugs

4) By End-User: Hospitals; Homecare; Specialty Centers; Other End-Users

Subsegments:

1) By Superficial Peritoneal Lesion: Endometriotic Nodules; Peritoneal Endometriosis

2) By Endometrioma: Chocolate Cysts

3) By Deeply Infiltrating Endometriosis: Bowel Endometriosis; Ureteral Endometriosis; Vaginal Endometriosis

4) By Other Types: Abdominal Endometriosis; Thoracic Endometriosis

Which Emerging Trends Are Reshaping The Endometriosis Market Landscape?

Leading businesses in the endometriosis market are concentrating on the advancement of innovative drugs like Myfembree and obtaining necessary authorizations to offer new treatment options for patients. The creation of new endometriosis drugs fulfills a previously unaddressed need for effective therapies. In August 2022, for example, Myovant Sciences GmbH, a biopharmaceutical firm in Switzerland, partnered with Pfizer Inc., an American pharmaceutical corporation, to gain U.S. Food and Drug Administration (FDA) approval for Myfembree. This drug is designed to manage moderate to severe pain related to endometriosis in premenopausal women. Myfembree, a once-daily medication, incorporates three crucial components: relugolix, estradiol, and norethindrone acetate. It provides validated relief for premenopausal women with two indications in one capsule, creating a new treatment alternative for women who cannot or choose not to utilize hormone therapy.

Which Firms Are Driving Innovation Within The Endometriosis Market?

Major companies operating in the endometriosis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck And Co. Inc., Abbvie Inc., Bayer AG, Bristol-Myers Squibb Company, GlaxoSmithKline PLC, AstraZeneca PLC, Abbott Laboratories, Eli Lilly and Company, Mylan N.V., Astellas Pharma Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Limited, Ipsen Pharma Biotech S.A.S., Cadila Pharmaceuticals Ltd., Gedeon Richter PLC, Torrent Pharmaceuticals Ltd., Neurocrine Biosciences Inc., Ferring Pharmaceuticals, Prestige Consumer Healthcare Inc., Almirall S.A, Evotec BioSystems GmbH, Serum Institute of India Pvt. Ltd., Kissei Pharmaceutical Co. Ltd., Sanofi India Ltd., DebioPharm Group, Repros Therapeutics Inc., Meditrina Pharmaceuticals Private Limited, Zenomed Healthcare Private Limited.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/endometriosis-global-market-report

What Are The Emerging Regional Trends Driving The Endometriosis Market?

North America was the largest region in the endometriosis market in 2024. The regions covered in endometriosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=13035&type=smp

Browse Through More Reports Similar to the Global Endometriosis Market 2025, By The Business Research Company

Female Fertility And Pregnancy Rapid Test Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/female-fertility-and-pregnancy-rapid-test-global-market-report

Fertility Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fertility-drugs-global-market-report

Fertility Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fertility-services-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model